Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor
- Nature. 2021 Oct;598(7882):672-676. doi: 10.1038/s41586-021-03963-9.
- 1. Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA.
- 2. Department of Medicine, Washington University School of Medicine, St Louis, MO, USA.
- 3. Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 4. Department of Medicine, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 5. Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 6. The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 7. Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 8. Department of Molecular Microbiology, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 9. The Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St Louis, MO, USA. [email protected].
- 10. Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St Louis, MO, USA. [email protected].
LDLRAD3 is a recently defined attachment and entry receptor for Venezuelan equine Encephalitis virus (VEEV)1, a New World alphavirus that causes severe Neurological Disease in humans. Here we present near-atomic-resolution cryo-electron microscopy reconstructions of VEEV virus-like particles alone and in a complex with the ectodomains of LDLRAD3. Domain 1 of LDLRAD3 is a low-density lipoprotein receptor type-A module that binds to VEEV by wedging into a cleft created by two adjacent E2-E1 heterodimers in one trimeric spike, and engages domains A and B of E2 and the fusion loop in E1. Atomic modelling of this interface is supported by mutagenesis and anti-VEEV antibody binding competition assays. Notably, VEEV engages LDLRAD3 in a manner that is similar to the way that arthritogenic alphaviruses bind to the structurally unrelated MXRA8 receptor, but with a much smaller interface. These studies further elucidate the structural basis of alphavirus-receptor interactions, which could inform the development of therapies to mitigate Infection and disease against multiple members of this family.